Publication:
Tuberculosis Treatment Failure: Causes and Solutions

dc.contributor.authorsClark, Philip Martin; Apikoglu-Rabus, Sule
dc.contributor.editorNguy, S
dc.contributor.editorKung, Z
dc.date.accessioned2022-03-11T21:33:39Z
dc.date.accessioned2026-01-11T16:01:33Z
dc.date.available2022-03-11T21:33:39Z
dc.date.issued2010
dc.description.abstractThe article attempts to examine the main reasons why the treatment of tuberculosis is not always successful, and to propose possible solutions to address this failure. In the introductory section a brief review of tuberculosis epidemiology includes encouraging global progress over the past twenty years tempered by some ongoing areas of concern. The main reasons for treatment failure are thought to be drug resistance and non-adherence to therapy. The first major reason for treatment failure is resistance to anti-tuberculosis agents. The underlying causes of this drug resistance and the types of drug resistance that a practitioner may encounter, is briefly explained. One of the areas of concern mentioned above is the relatively high levels of multiple-drug resistance tuberculosis (MDR-TB) in Eastern Europe, former Soviet countries and in densely populated Asian countries. To this should be added the disturbing emergence of extensive drug resistance (XDR-TB). Successful treatment approaches in managing drug resistance and barriers to effective treatment outcomes are also concisely dealt with. The second foremost cause of treatment failure is non-adherence. In the opening section dealing with this topic, the terms adherence and non-adherence are defined; this is followed by a succinct section on how adherence can be evaluated and factors which can affect adherence, either positively or negatively. A slightly more expanded section deals with the important topic of how adherence to TB treatment can be improved by focusing on patient-centered strategies. Following this, the benefits of directly observed therapy (DOT) as a way of ensuring adherence is discussed, and an overview of the success of DOT programs is provided, both in terms of patients with drug sensitive and drug resistant tuberculosis. The pharmaco-economic implications of DOT strategies are also alluded to in a few words. In the final section, a number of possible solutions to prevent and overcome the problem of treatment failure is brought together is the form of a list of proposals. Most of these proposed solutions are already mentioned in the main body of the text.
dc.identifier.doidoiWOS:000280112300011
dc.identifier.isbn978-1-60876-055-8
dc.identifier.urihttps://hdl.handle.net/11424/222746
dc.identifier.wosWOS:000280112300011
dc.language.isoeng
dc.publisherNOVA SCIENCE PUBLISHERS, INC
dc.relation.ispartofDRUG-RESISTANT TUBERCULOSIS: CAUSES, DIAGNOSIS AND TREATMENTS
dc.relation.ispartofseriesVirology Research Progress
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMULTIDRUG-RESISTANT TUBERCULOSIS
dc.subjectDIRECTLY OBSERVED THERAPY
dc.subjectMYCOBACTERIUM-TUBERCULOSIS
dc.subjectPATIENT EDUCATION
dc.subjectDRUG-RESISTANCE
dc.subjectPYRAZINAMIDE
dc.subjectPREVENTION
dc.subjectRIFAMPICIN
dc.subjectADHERENCE
dc.subjectREGIMENS
dc.titleTuberculosis Treatment Failure: Causes and Solutions
dc.typebookPart
dspace.entity.typePublication
oaire.citation.endPage307
oaire.citation.startPage287
oaire.citation.titleDRUG-RESISTANT TUBERCULOSIS: CAUSES, DIAGNOSIS AND TREATMENTS

Files